{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T06:49:01Z","timestamp":1776494941128,"version":"3.51.2"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>The latest world malaria report revealed that human deaths caused by malaria are currently on the rise and presently stood at over 627,000 per year. In addition, more than 240 million people have the infection at any given time. These figures make malaria the topmost infectious disease and reiterate the need for continuous efforts for the development of novel chemotherapies. Malaria is an infectious disease caused majorly by the protozoan intracellular parasite <jats:italic>Plasmodium falciparum<\/jats:italic> and transmitted by mosquitoes. Reports abound on the central role of falcipains (cysteine protease enzymes) in the catabolism of hemoglobin for furnishing the plasmodium cells with amino acids that they require for development and survival in the hosts. Even though falcipains (FPs) have been validated as drug target molecules for the development of new antimalarial drugs, none of its inhibitory compounds have advanced beyond the early discovery stage. Therefore, there are renewed efforts to expand the collection of falcipain inhibitors. As a result, an interesting finding reported the discovery of a quinolinyl oxamide derivative (QOD) and an indole carboxamide derivative (ICD), with each compound demonstrating good potencies against the two essential FP subtypes 2 (FP-2) and 3 (FP-3). In this study, we utilized microsecond-scale molecular dynamics simulation computational method to investigate the interactions between FP-2 and FP-3 with the quinolinyl oxamide derivative and indole carboxamide derivative. The results revealed that quinolinyl oxamide derivative and indole carboxamide derivative bound tightly at the active site of both enzymes. Interestingly, despite belonging to different chemical scaffolds, they are coordinated by almost identical amino acid residues <jats:italic>via<\/jats:italic> extensive hydrogen bond interactions in both FP-2 and FP-3. Our report provided molecular insights into the interactions between FP-2 and FP-3 with quinolinyl oxamide derivative and indole carboxamide derivative, which we hope will pave the way towards the design of more potent and druglike inhibitors of these enzymes and will pave the way for their development to new antimalarial drugs.<\/jats:p>","DOI":"10.3389\/fmolb.2022.1070080","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T06:12:30Z","timestamp":1671430350000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Microsecond-long simulation reveals the molecular mechanism for the dual inhibition of falcipain-2 and falcipain-3 by antimalarial lead compounds"],"prefix":"10.3389","volume":"9","author":[{"given":"Ammar Usman","family":"Danazumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel Oluwadare","family":"Balogun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s41182-016-0039-0","article-title":"Global warming and the possible globalization of vector-borne diseases: A call for increased awareness and action","volume":"44","author":"Balogun","year":"2016","journal-title":"Trop. Med. Health"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.3390\/IJMS20112783","article-title":"A structure-based drug discovery paradigm","volume":"20","author":"Batool","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0010-4655(95)00042-E","article-title":"Gromacs: A message-passing parallel molecular dynamics implementation","volume":"91","author":"Berendsen","year":"1995","journal-title":"Comput. Phys. Commun."},{"key":"B4","doi-asserted-by":"publisher","first-page":"014101","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J. Chem. Phys."},{"key":"B5","volume-title":"Amber 2017 reference ManAMBER 2017","author":"Case","year":"2017"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/J.BMC.2015.02.062","article-title":"Identification of novel class of falcipain-2 inhibitors as potential antimalarial agents","volume":"23","author":"Chakka","year":"2015","journal-title":"Bioorg Med. Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/(sici)1521-3773(19990115)38:1\/2<236:aid-anie236>3.0.co;2-m","article-title":"Peptide folding: When simulation meets experiment","volume":"31","author":"Daura","year":"1998","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"B8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/MED.20163","article-title":"Falcipain-2 inhibitors","volume":"30","author":"Ettari","year":"2010","journal-title":"Med. Res. Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.2174\/0929867327666200730215316","article-title":"Falcipain-2 and falcipain-3 inhibitors as promising antimalarial agents","volume":"28","author":"Ettari","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"B11","doi-asserted-by":"publisher","first-page":"W368","DOI":"10.1093\/NAR\/GKI464","article-title":"H++: A server for estimating pKas and adding missing hydrogens to macromolecules","volume":"33","author":"Gordon","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1182\/BLOOD-2002-01-0101","article-title":"Plasmodium falciparum cysteine protease falcipain-2 cleaves erythrocyte membrane skeletal proteins at late stages of parasite development","volume":"100","author":"Hanspal","year":"2002","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1021\/acs.jcim.1c01189","article-title":"Tetracycline derivatives inhibit plasmodial cysteine protease falcipain-2 through binding to a distal allosteric site","volume":"62","author":"Hernandez Gonzalez","year":"2022","journal-title":"J. Chem. Inf. Model"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/J.BMCL.2018.03.058","article-title":"Designing novel inhibitors against falcipain-2 of Plasmodium falciparum","volume":"28","author":"Himangini","year":"2018","journal-title":"Bioorg Med. Chem. Lett."},{"key":"B15","doi-asserted-by":"publisher","first-page":"25425","DOI":"10.1074\/JBC.M603776200","article-title":"Structural and functional characterization of Falcipain-2, a hemoglobinase from the malarial parasite Plasmodium falciparum","volume":"281","author":"Hogg","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/J.NEURON.2018.08.011","article-title":"Molecular dynamics simulation for all","volume":"99","author":"Hollingsworth","year":"2018","journal-title":"Neuron"},{"key":"B17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1021\/ci100275a","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations","volume":"51","author":"Hou","year":"2011","journal-title":"J. Chem. Inf. Model"},{"key":"B18","doi-asserted-by":"publisher","first-page":"25697","DOI":"10.1074\/JBC.M109.014340","article-title":"Vinyl sulfones as antiparasitic agents and a structural basis for drug design","volume":"284","author":"Kerr","year":"","journal-title":"J. Biol. Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1021\/JM8013663","article-title":"Structures of falcipain-2 and falcipain-3 bound to small molecule inhibitors: Implications for substrate specificity","volume":"52","author":"Kerr","year":"","journal-title":"J. Med. Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/jb\/mvt096","article-title":"Synergy of ferrous ion on 5-aminolevulinic acid-mediated growth inhibition of Plasmodium falciparum","volume":"154","author":"Komatsuya","year":"2013","journal-title":"J. Biochem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/S12936-019-3043-0","article-title":"The complex of Plasmodium falciparum falcipain-2 protease with an (E)-chalcone-based inhibitor highlights a novel, small, molecule-binding site","volume":"18","author":"Machin","year":"2019","journal-title":"Malar. J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2174\/156802612799362913","article-title":"Falcipain inhibition as a promising antimalarial target","volume":"12","author":"Marco","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12864-015-1306-X\/TABLES\/5","article-title":"Functional analysis of C1 family cysteine peptidases in the larval gut of Tenebrio molitor and Tribolium castaneum","volume":"16","author":"Martynov","year":"2015","journal-title":"BMC Genomics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0968-0896(99)00008-5","article-title":"Cysteine protease inhibitors as chemotherapy for parasitic infections","volume":"7","author":"McKerrow","year":"1999","journal-title":"Bioorg Med. Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"345195","DOI":"10.1155\/2012\/345195","article-title":"Structure-function of falcipains: Malarial cysteine proteases","volume":"2012","author":"Pandey","year":"2012","journal-title":"J. Trop. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"16193","DOI":"10.1038\/s41598-018-34564-8","article-title":"Allosteric site inhibitor disrupting auto-processing of malarial cysteine proteases","volume":"8","author":"Pant","year":"2018","journal-title":"Sci. Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: A new molecular dynamics method","volume":"52","author":"Parrinello","year":"1998","journal-title":"J. Appl. Phys."},{"key":"B28","doi-asserted-by":"publisher","first-page":"6911","DOI":"10.1021\/acs.jmedchem.7b00405","article-title":"Development of novel peptide-based michael acceptors targeting rhodesain and falcipain-2 for the treatment of neglected tropical diseases (NTDs)","volume":"60","author":"Previti","year":"2017","journal-title":"J. Med. Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"10096","DOI":"10.1063\/1.1808117","article-title":"A modified TIP3P water potential for simulation with Ewald summation","volume":"121","author":"Price","year":"2004","journal-title":"J. Chem. Phys."},{"key":"B30","doi-asserted-by":"publisher","first-page":"115155","DOI":"10.1016\/J.BMC.2019.115155","article-title":"Identification of antimalarial leads with dual falcipain-2 and falcipain-3 inhibitory activity","volume":"28","author":"Rana","year":"2020","journal-title":"Bioorg Med. Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"140362","DOI":"10.1016\/J.BBAPAP.2020.140362","article-title":"Falcipain cysteine proteases of malaria parasites: An update","volume":"1868","author":"Rosenthal","year":"2020","journal-title":"Biochimica Biophysica Acta (BBA) - Proteins Proteomics"},{"key":"B32","volume-title":"Schr\u00f6dinger release 2022-1","year":"2022"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0006512","DOI":"10.1371\/JOURNAL.PNTD.0006512","article-title":"Cysteine proteases in protozoan parasites","volume":"12","author":"Siqueira-Neto","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12916-014-0254-7","article-title":"Global malaria eradication and the importance of Plasmodium falciparum epidemiology in Africa","volume":"13","author":"Snow","year":"2015","journal-title":"BMC Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"6960","DOI":"10.1128\/AAC.01910-15","article-title":"In vivo curative and protective potential of orally administered 5-aminolevulinic acid plus ferrous ion against malaria","volume":"59","author":"Suzuki","year":"2015","journal-title":"Antimicrob. agents Chemother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"Gmx_MMPBSA: A new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/JCC.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"B38","unstructured":"World health organization2022"}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2022.1070080\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T06:12:35Z","timestamp":1671430355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2022.1070080\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,19]]},"references-count":38,"alternative-id":["10.3389\/fmolb.2022.1070080"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2022.1070080","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,19]]},"article-number":"1070080"}}